IART

Integra LifeSciences Holdings

IART.US integralife.com + Research + Basket
CIK 0000917520
Employees 4,427
Phone 609 275 0500
Fiscal year end December
IPO Aug 16, 1995
Address 1100 Campus Road, Princeton, NJ, United States, 08540
12.69
-0.14 (-1.09%)
USD · NASDAQ
52-week range
8.70
20.49
Trading at 34% of the 52-week range
Market Cap
997.82M
P/E Ratio
75.47
Forward P/E
4.59
Book Value
13.71
Div. Yield
N/A
% Institutions
98.63%
% Insiders
14.38%

1 Year

-16.9%

3 Year

-63.4%

10 Year

-67.7%
Description

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Actions

Add an action for IART.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Stuart M. Essig Ph.D. CEO, President & Chairman 1962
Ms. Lea Daniels Knight Executive VP & CFO 1972
Mr. Robert T. Davis Jr. Executive Vice President of Tissue Reconstruction and Distributed Technologies 1959
Mr. Michael J. McBreen Executive VP & Chief Commercial Officer 1966
Mr. Harvinder Pal Singh Executive VP & President of International Business 1966
Mr. Jeffrey A. Mosebrook Senior VP of Finance & Principal Accounting Officer 1976
Mr. Teshtar Elavia Corporate VP & Chief Technology Officer NA
Christopher Ward Senior Director of Investor Relations NA
Mr. Michael D. Hutchinson Executive VP, Chief Legal Officer & Secretary 1971
Laurene Isip Vice President of Global Corporate Communications & Public Relations NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Nov 05, 2025 Jeffrey A Graves N/A Purchase 9.00K $11.35 $102.15K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 10.68M Jun 30, 2026 13.74% $0.00 3.54%
Rubric Capital Management LP 7.75M Jun 30, 2026 9.97% $1.28 0.00%
Amvescap Plc. 3.75M Jun 30, 2026 4.82% $0.01 7.57%
Vanguard Portfolio Management, LLC 3.74M Jun 30, 2026 4.81% $0.00 1.53%
Morgan Stanley - Brokerage Accounts 3.59M Jun 30, 2026 4.62% $0.00 0.25%
Paradigm Capital Management, Inc. 3.44M Jun 30, 2026 4.42% $1.68 -14.29%
Fuller & Thaler Asset Management Inc 3.44M Jun 30, 2026 4.42% $0.17 -2.65%
State Street Corp 2.95M Jun 30, 2026 3.79% $0.00 2.09%
Vanguard Capital Management, LLC 2.95M Jun 30, 2026 3.79% $0.00 1.91%
Neuberger Berman Group LLC 2.36M Jun 30, 2026 3.04% $0.03 11.80%
Dimensional Fund Advisors, Inc. 2.22M Jun 30, 2026 2.85% $0.01 -20.12%
Geode Capital Management, LLC 1.79M Jun 30, 2026 2.30% $0.00 8.13%
The Goldman Sachs Group Inc 1.47M Jun 30, 2026 1.89% $0.00 -21.47%
Wellington Management Company LLP 1.46M Jun 30, 2026 1.88% $0.00 12.37%
Millennium Management LLC 1.44M Jun 30, 2026 1.85% $0.01 131.15%
Charles Schwab Investment Management Inc 1.40M Jun 30, 2026 1.80% $0.00 -13.07%
Bank of America Corp 1.33M Jun 30, 2026 1.71% $0.00 -6.03%
Systematic Financial Management LP 1.02M Jun 30, 2026 1.32% $0.37 -3.40%
Allianz Asset Management AG 1.01M Jun 30, 2026 1.29% $0.01 12.99%
Glenmede Trust Co NA 948.14K Jun 30, 2026 1.22% $0.08 -3.71%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 3.93M 5.06% ▲ 0.03% Sep 30, 2026
2 Invesco Small Cap Value A 3.60M 4.63% ▲ 6.30% Aug 31, 2026
3 Undiscovered Managers Behavioral Val L 2.71M 3.48% ▼ 2.18% Aug 31, 2026
4 Vanguard MStar Total Stk Mkt Idx Invest 2.11M 2.71% ▲ 0.00% Sep 30, 2026
5 iShares Russell 2000 ETF 1.77M 2.27% ▼ 1.14% Sep 30, 2026
6 Vanguard Small Cap Index 1.49M 1.91% ▼ 2.03% Sep 30, 2026
7 Vanguard MStar Small Cap Value Index 968.70K 1.25% ▲ 0.25% Sep 30, 2026
8 Glenmede Small Cap Equity Adv 771.51K 0.99% ▼ 10.19% Sep 30, 2026
9 Fidelity Small Cap Index 748.05K 0.96% ▲ 0.89% Jul 31, 2026
10 PIMCO RAE US Small Instl 650.69K 0.84% ▲ 5.12% Jun 30, 2026

Financial Highlights

▼
Market Cap: $997.82M
EBITDA: $317.82M
P/E Ratio: $75.47
PEG Ratio: $0.71
Book Value: $13.71
Earnings/Share: $0.17
Profit Margin: 0.79%
Operating Margin: 10.13%
ROA (TTM): 2.86%
ROE (TTM): 1.24%
Revenue (TTM): $1.66B
Revenue/Share (TTM): $21.49
Earnings Growth (YOY): 0.40%
Revenue Growth (YOY): 2.30%

Valuation Metrics

Enterprise Value: $801.87M
Trailing P/E: 75.47
Forward P/E: 4.59

Shares Statistics

Shares Outstanding: 77.77M
Shares Float: 58.64M
% Insiders: 14.38%
% Institutions: 98.63%
Shares Short: 7.32M
Shares Short (Prior Month): 7.27M
Short Ratio: 6.30
Short % Float: 12.97%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$1.64B
Cost of Goods Sold
adjust
$-790.01M
Gross Profit
subtotal
$845.23M
SG&A
adjust
$-699.70M
R&D
adjust
$-98.97M
Operating Income
subtotal
$68.32M
Other / Non-Operating Items
adjust
$-584.79M
Net Income
subtotal
$-516.47M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about IART.US!